Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006
2010
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules
2011
Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry
2010
Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: The Innohep® in Renal Insufficiency Study (IRIS)
2011
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
Co‐occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines
2017
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Evidence-Based Management of Anticoagulant Therapy
2012
Contribution of platelets to tumour metastasis
2011 Standout
The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study
2013
Antithrombotic Therapy for VTE Disease
2016 Standout
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: a prospective, randomized, open, multicentre trial
2006
Can Selected Patients With Newly Diagnosed Pulmonary Embolism Be Safely Treated Without Hospitalization? A Systematic Review
2012
The Peripheral Arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population
2010
Diagnosis of DVT
2012
Pulmonary embolism and deep vein thrombosis
2012
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism
2010
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
CT Scan Findings in Chronic Thromboembolic Pulmonary Hypertension
2005
Prevention of Venous Thromboembolism
2004 Standout
Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome
2006
Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting
2012
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
The Inferior Vena Cava Filter
2013
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Clopidogrel and proton pump inhibitors - where do we stand in 2012?
2012
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
2015
Prevention of Venous Thromboembolism
2008 Standout
Current approaches and controversial issues in the diagnosis of deep vein thrombosis via duplex Doppler ultrasound
2006
Survival Effects of Inferior Vena Cava Filter in Patients With Acute Symptomatic Venous Thromboembolism and a Significant Bleeding Risk
2014
A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both
2008
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
2011
Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review
2009
Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin
2013
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Bed Rest or Ambulation in the Initial Treatment of Patients With Acute Deep Vein Thrombosis or Pulmonary Embolism
2005
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
2012
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Down Syndrome
2020 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Comparative Outcomes of Catheter-Directed Thrombolysis Plus Anticoagulation vs Anticoagulation Alone to Treat Lower-Extremity Proximal Deep Vein Thrombosis
2014
Antiplatelet Therapy and Proton Pump Inhibition
2012
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The Wells Rule Does Not Adequately Rule Out Deep Venous Thrombosis in Primary Care Patients
2005
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients
2017
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
2007
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation
2012
Interventions for enhancing medication adherence
2014 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Systematic Review: d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
2008
Invasive Approaches to Treatment of Venous Thromboembolism
2004
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
2005
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Medication Adherence
2009 Standout
Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage
2014
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Carmen Suárez being referenced
Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry
2008
Modificación de la estratificación del riesgo vascular tras la determinación del índice tobillo-brazo en pacientes sin enfermedad arterial conocida. Estudio MERITO
2007
Evaluation of the impact of abdominal obesity on glucose and lipid metabolism disorders in adults with Down syndrome
2014
Clinical profile and main comorbidities of Spanish adults with Down syndrome
2015
Concomitant Use of Proton Pump Inhibitors and Clopidogrel in Patients With Coronary, Cerebrovascular, or Peripheral Artery Disease in the Factores de Riesgo y ENfermedad Arterial (FRENA) Registry
2010
Management of Patients with Acute Venous Thromboembolism: Findings from the RIETE Registry
2003
Rapid D-dimer test combined a clinical model for deep vein thrombosis
2004
Clinical Validity of Negative Helical Computed Tomography for Clinical Suspicion of Pulmonary Embolism
2004
The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients
2003
Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio
2017
Multicenter Cluster-Randomized Trial of a Multifactorial Intervention to Improve Antihypertensive Medication Adherence and Blood Pressure Control Among Patients at High Cardiovascular Risk (The COM99 Study)
2010
Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE).
2006
Deep Vein Thrombosis
2002
A Cross-Sectional Study of the Phenotypes of Obesity and Insulin Resistance in Adults with Down Syndrome
2014